{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/65569276"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "The FDA also proposed a label for all ephedra-containing dietary supplements that warns about the risks of serious adverse events, including heart attack, seizure, stroke, and death, and cautions that these risks can increase with the dose, strenuous exercise, and with the concomitant use of other stimulants such as caffeine." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "aafp.org" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/114670997"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/65569276" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/32026778"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/65569276"] } } }
